Latest filing published 30 Nov 2016 for Sucampo Pharmaceuticals, Inc., €104k.
Insider track record
Daniel P. Getman: trading record in brief
This profile gathers the share dealings of Daniel P. Getman in Sucampo Pharmaceuticals, Inc. Over a trading history stretching from 28 August 2015 to 29 November 2016, the count stands at 7 filings.
The open-market record consists of 3 sales worth €1.1M, with no purchase. Other entries cover 1 share grant and 3 option exercises. So far in 2016, the count stands at no purchases and 2 sales.
Most recently, on 30 November 2016, the filings show an option exercise worth €24k in Sucampo Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Daniel P. Getman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,201 shares@ US$6.8023.3% of flowCommon Stock, Class ASEC:0001171843-16-013440:0
- 16,201 shares@ US$16.8957.8% of flowCommon Stock, Class ASEC:0001171843-16-013440:1
- 3,799 shares@ US$6.805.5% of flowCommon Stock, Class ASEC:0001171843-16-013440:2
- 3,799 shares@ US$16.7513.4% of flowCommon Stock, Class ASEC:0001171843-16-013440:3
- 9,800 shares0Common StockSEC:0001171843-16-010520:0
- 30,000 shares@ US$3.20Class A Common StockSEC:0001171843-15-004973:0
- 30,000 shares@ US$28.14Class A Common StockSEC:0001171843-15-004973:1
7 of 7 declarations
